Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...

explored a novel radiomic nomogram that effectively differentiates parotid pleomorphic adenoma (PA ... accurate method for distinguishing between these two common parotid gland tumors. This innovative ...

Pembrolizumab is under clinical development by Merck and currently in Phase I for Kaposi Sarcoma. According to GlobalData, Phase I drugs for Kaposi Sarcoma have an 84% phase transition success rate ...

JS-001 is under development for the treatment of advanced resectable oral squamous cell carcinoma (OSCC), locally advanced anal canal squamous carcinoma, intrahepatic cholangiocarcinoma, salivary ...

Here’s everything you need to know about the kind of cancer Milla has in Netflix’s Apple Cider Vinegar show… ...

Headache is common among patients diagnosed with pituitary adenoma (PA). There are still controversies regarding the headache presentation, pathophysiology and outcome after treatment in these ...

Many non-mammalian vertebrates like fish, however, are known to detect color and brightness with the pineal gland, which is part of the brain. An Osaka Metropolitan University research group has ...

4). Because parotid stones are uncommon, this procedural approach is not cost effective. Evaluation of gland function is best accomplished via a scintigraphic examination with the intravenously ...

Cenexi Revenue: EUR41 million for Q3 FY25. Cenexi Gross Margin: 77% for Q3 FY25, up from 75% in Q3 FY24. Gland Pharma Ltd (NSE:GLAND) reported a consolidated EBITDA margin of 46% for Q3 FY25, a 100 ...

One 97 Communications Paytm, Zomato, APL Apollo Tubes, Central Bank of India, Dixon Technologies, IDBI Bank, Indian Overseas Bank, Indian Railway Finance Corporation, ICICI Securities, Jammu ...

eAArly DETECT 2 feasibility study designed to validate earlier results on advanced adenomas over a large population of average risk patients Multi-center study expected to complete enrollment in ...